研究成果
年分
作者
期刊
研究名稱
2020
Chang CY, Hung GU, Hsu BL, Yang BH, Chang CW, Hu LH, Huang WS, Wang HE, Wu TC, Liu RS*.
J Nucl Cardiol 2020;27:819-28. (IF: 3.366)
Simplified quantification of (13) N-ammonia PET myocardial blood flow: A comparative study with the standard compartment model to facilitate clinical use.
2020
Chang HC, Cheng HM, Huang WM, Lee CW, Guo CY, Yu WC, Chen CH, Sung SH.*
J Chin Med Assoc 2020;83:544-50. (IF: 2.170)
Risk stratification in patients hospitalized for acute heart failure in Asian population.
2020
Chang HC, Huang CJ, Cheng HM, Yu WC, Chiang CE, Sung SH*, Chen CH*.
ESC Heart Fail 2020;7:2807-17. (IF: 3.902)
Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure.
2020
Chang HH, Chen PL, Leu HB, Chen IM, Wu NY, Chen YH*.
BMC Cardiovasc Disord 2020;20:283. (IF: 2.078)
Sex difference in the prognostic role of body composition parameters in Taiwanese patients undergoing transcatheter aortic valve implantation.
2020
Chang JH, Cheng CC, Lu YY, Chen YC, Chen SA, Chen YJ*.
Iran J Basic Med Sci 2020;23 865-70. (IF:2.146)
Trastuzumab increases pulmonary vein arrhythmogenesis through modulating pulmonary vein electrical and conduction properties via phosphatidylinositol 3-kinase signaling.
2020
Chang LH, Hwu CM, Lin YC, Huang CC, Won JGS, Chen HS, Lin LY*.
Endocr Pract 2020;26:1115-24. (IF: 3.869)
Soluble tumor necrosis factor receptor type 1 levels exhibit the better association with renal outcomes than traditional risk factors in Chinese subjects with type 2 diabetes mellitus.
2020
Chang TI, Chen CH, Hsieh HL, Chen CY, Hsu SC, Cheng HS, Huang WC, Sue YM, Hsu YH, Lin FY, Shih CM, Lin SJ, Huang PH, Liu CT*.
Sci Rep 2020;10:12135. (IF: 3.998)
Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula.
2020
Chang TT, Chen JW*.
Pharmacol Res 2020;151:104509. (IF:5.893)
Hydralazine improves ischemia-induced neovasculogenesis via xanthine-oxidase inhibition in chronic renal insufficiency.
2020
Chang TT, Chen JW*.
Int J Mol Sci 2020;21:3172. (IF: 4.556)
The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy.
2020
Chang TT, Yang HY, Chen C, Chen JW.
Int J Mol Sci 2020;21:6567. (IF:4.556)
CCL4 Inhibition in Atherosclerosis: Effects on Plaque Stability, Endothelial Cell Adhesiveness, and Macrophages Activation.